Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Overland Park, KA
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
mi
from
Bogota,
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
mi
from
Bogota,
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Kissimmee, FL
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Atlanta, GA
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Hoffman Estates, IL
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Cedarhurst, NY
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Austin, TX
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
mi
from
Banfield,
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
mi
from
Banfield,
Click here to add this to my saved trials
Cognitive Enhancement Therapy for Early-Stage Schizophrenia
Rehabilitation, Brain Function and Early Schizophrenia
Status: Enrolling
Updated:  11/2/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Cognitive Enhancement Therapy for Early-Stage Schizophrenia
Rehabilitation, Brain Function and Early Schizophrenia
Status: Enrolling
Updated: 11/2/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Lifestyle Modification for Weight Loss in Schizophrenia
Lifestyle Modification for Weight Loss in Schizophrenia
Status: Enrolling
Updated:  11/4/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
Lifestyle Modification for Weight Loss in Schizophrenia
Lifestyle Modification for Weight Loss in Schizophrenia
Status: Enrolling
Updated: 11/4/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia
A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia
Status: Enrolling
Updated:  11/4/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia
A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia
Status: Enrolling
Updated: 11/4/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia
An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia
Status: Enrolling
Updated:  11/4/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia
An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia
Status: Enrolling
Updated: 11/4/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness
"My Coach Connect": Pilot Under the Partnered Research Center for Quality Care, RHINO 2008-0132
Status: Enrolling
Updated:  11/5/2015
ROADS (Recovery, Opportunity, And Developing Skills)
mi
from
Long Beach, CA
My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness
"My Coach Connect": Pilot Under the Partnered Research Center for Quality Care, RHINO 2008-0132
Status: Enrolling
Updated: 11/5/2015
ROADS (Recovery, Opportunity, And Developing Skills)
mi
from
Long Beach, CA
Click here to add this to my saved trials
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality
Status: Enrolling
Updated:  11/19/2015
VA Puget Sound Health Care System
mi
from
Tacoma and Seattle, WA
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality
Status: Enrolling
Updated: 11/19/2015
VA Puget Sound Health Care System
mi
from
Tacoma and Seattle, WA
Click here to add this to my saved trials
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
Status: Enrolling
Updated:  11/30/2015
Outpatient clinics within the University of Maryland Division of Community Psychiatry
mi
from
Baltimore, MD
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
Status: Enrolling
Updated: 11/30/2015
Outpatient clinics within the University of Maryland Division of Community Psychiatry
mi
from
Baltimore, MD
Click here to add this to my saved trials
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes in Individuals Extensively Diagnosed and Genotyped
Status: Enrolling
Updated:  12/2/2015
VA Eastern Colorado Health Care System, Denver
mi
from
Denver, CO
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes in Individuals Extensively Diagnosed and Genotyped
Status: Enrolling
Updated: 12/2/2015
VA Eastern Colorado Health Care System, Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
A 28-week, Randomised, Open-label Study Evaluating the Effectiveness of Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
US002
mi
from
Los Angeles, CA
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
A 28-week, Randomised, Open-label Study Evaluating the Effectiveness of Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
US002
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
A 28-week, Randomised, Open-label Study Evaluating the Effectiveness of Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
US006
mi
from
San Diego, CA
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
A 28-week, Randomised, Open-label Study Evaluating the Effectiveness of Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
US006
mi
from
San Diego, CA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Shanti Clinical Trials
mi
from
Colton, CA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Shanti Clinical Trials
mi
from
Colton, CA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Stanford University
mi
from
Palo Alto, CA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Yale University
mi
from
New Haven, CT
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Mental Health Advocates
mi
from
Boca Raton, FL
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Mental Health Advocates
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Miami School of Medicine
mi
from
Miami, FL
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Emory University
mi
from
Atlanta, GA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Medical College of Georgia
mi
from
Augusta, GA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Iowa
mi
from
Iowa City, IA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Clinical Research Institute
mi
from
Wichita, KA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Clinical Research Institute
mi
from
Wichita, KA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Lousiana State University Health Sciences Center
mi
from
Shreveport, LA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Lousiana State University Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Clinical Insights Inc
mi
from
Glen Burnie, MD
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Clinical Insights Inc
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Freedom Trail Clinic
mi
from
Boston, MA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Freedom Trail Clinic
mi
from
Boston, MA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
John C Corrigan Community Mental Health Center
mi
from
Fall River, MA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
John C Corrigan Community Mental Health Center
mi
from
Fall River, MA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Massachusetts
mi
from
Worcester, MA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Wayne State University
mi
from
Detroit, MI
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
New Mexico VA Healthcare System
mi
from
Albuquerque, NM
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
New Mexico VA Healthcare System
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Rochester
mi
from
Rochester, NY
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
John Umstead Hospital/Duke University
mi
from
Butner, NC
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
John Umstead Hospital/Duke University
mi
from
Butner, NC
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Carolinas HealthCare System
mi
from
Charlotte, NC
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Carolinas HealthCare System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Philadelphia VA Medical Center-116A
mi
from
Philadelphia, PA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Philadelphia VA Medical Center-116A
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Baylor College of Medicine
mi
from
Houston, TX
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
Status: Enrolling
Updated:  12/8/2015
Northwestern University Department of Psychiatry and Behavioral Sciences
mi
from
Chicago, IL
High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
Status: Enrolling
Updated: 12/8/2015
Northwestern University Department of Psychiatry and Behavioral Sciences
mi
from
Chicago, IL
Click here to add this to my saved trials
Regulation of Arginine-vasopressin (AVP)
Regulation of Arginine-vasopressin (AVP) in Psychiatric Disorders
Status: Enrolling
Updated:  12/8/2015
The John Pierce Laboratory
mi
from
New Haven, CT
Regulation of Arginine-vasopressin (AVP)
Regulation of Arginine-vasopressin (AVP) in Psychiatric Disorders
Status: Enrolling
Updated: 12/8/2015
The John Pierce Laboratory
mi
from
New Haven, CT
Click here to add this to my saved trials
Regulation of Arginine-vasopressin (AVP)
Regulation of Arginine-vasopressin (AVP) in Psychiatric Disorders
Status: Enrolling
Updated:  12/8/2015
VA Connecticut Healthcare System
mi
from
West Haven, CT
Regulation of Arginine-vasopressin (AVP)
Regulation of Arginine-vasopressin (AVP) in Psychiatric Disorders
Status: Enrolling
Updated: 12/8/2015
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials